BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

375 related articles for article (PubMed ID: 27393267)

  • 1. The impact of pregnancy on anti-HIV activity of cervicovaginal secretions.
    Hughes BL; Dutt R; Raker C; Barthelemy M; Rossoll RM; Ramratnam B; Wira CR; Cu-Uvin S
    Am J Obstet Gynecol; 2016 Dec; 215(6):748.e1-748.e12. PubMed ID: 27393267
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro anti-HIV-1 activity in cervicovaginal secretions from pregnant and nonpregnant women.
    Anderson BL; Ghosh M; Raker C; Fahey J; Song Y; Rouse DJ; Wira CR; Cu-Uvin S
    Am J Obstet Gynecol; 2012 Jul; 207(1):65.e1-10. PubMed ID: 22727351
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Short communication: genital tumor growth factor-β1 levels in HIV-infected Indian women are associated with reduced levels of innate antimicrobial products and increased HIV shedding.
    Thakar M; Patil R; Shukre S; Bichare S; Kadam P; Khopkar P; Ghate M; Paranjape R
    AIDS Res Hum Retroviruses; 2014 Jul; 30(7):648-53. PubMed ID: 24547777
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cervicovaginal levels of lactoferrin, secretory leukocyte protease inhibitor, and RANTES and the effects of coexisting vaginoses in human immunodeficiency virus (HIV)-seronegative women with a high risk of heterosexual acquisition of HIV infection.
    Novak RM; Donoval BA; Graham PJ; Boksa LA; Spear G; Hershow RC; Chen HY; Landay A
    Clin Vaccine Immunol; 2007 Sep; 14(9):1102-7. PubMed ID: 17671228
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduced levels of genital tract immune biomarkers in postmenopausal women: implications for HIV acquisition.
    Jais M; Younes N; Chapman S; Cu-Uvin S; Ghosh M
    Am J Obstet Gynecol; 2016 Sep; 215(3):324.e1-324.e10. PubMed ID: 27026477
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Levels of Genital Tract Defensins and Cytokines Differ between HIV-Uninfected US and African Women.
    Murphy K; Richardson BA; Dezzutti CS; Marrazzo J; Hillier SL; Hendrix CW; Herold BC
    Am J Reprod Immunol; 2015 Oct; 74(4):313-22. PubMed ID: 26094732
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dysregulation in Genital Tract Soluble Immune Mediators in Postmenopausal Women Is Distinct by HIV Status.
    Ghosh M; Jais M; Delisle J; Younes N; Benyeogor I; Biswas R; Mohamed H; Daniels J; Wang C; Young M; Kassaye S
    AIDS Res Hum Retroviruses; 2019 Mar; 35(3):251-259. PubMed ID: 30618272
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of menopause on the innate antiviral activity of cervicovaginal lavage.
    Chappell CA; Isaacs CE; Xu W; Meyn LA; Uranker K; Dezzutti CS; Moncla BJ; Hillier SL
    Am J Obstet Gynecol; 2015 Aug; 213(2):204.e1-6. PubMed ID: 25818668
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of HIV-1 in the cervicovaginal secretions and blood of pregnant and nonpregnant women.
    Shaheen F; Sison AV; McIntosh L; Mukhtar M; Pomerantz RJ
    J Hum Virol; 1999; 2(3):154-66. PubMed ID: 10413367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of chronic sexual abuse and depression on inflammation and wound healing in the female reproductive tract of HIV-uninfected and HIV-infected women.
    Ghosh M; Daniels J; Pyra M; Juzumaite M; Jais M; Murphy K; Taylor TN; Kassaye S; Benning L; Cohen M; Weber K
    PLoS One; 2018; 13(6):e0198412. PubMed ID: 29894487
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biomarkers of Cervical Inflammation and Immunity Associated with Cervical Shedding of HIV-1.
    Mauck C; Chen PL; Morrison CS; Fichorova RN; Kwok C; Chipato T; Salata RA; Doncel GF
    AIDS Res Hum Retroviruses; 2016 May; 32(5):443-51. PubMed ID: 26650885
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pregnancy-induced changes in immune protection of the genital tract: defining normal.
    Anderson BL; Mendez-Figueroa H; Dahlke JD; Raker C; Hillier SL; Cu-Uvin S
    Am J Obstet Gynecol; 2013 Apr; 208(4):321.e1-9. PubMed ID: 23313311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of High-Risk Human Papillomavirus with Genital Tract Mucosal Immune Factors in HIV-Infected Women.
    Buckley N; Huber A; Lo Y; Castle PE; Kemal K; Burk RD; Strickler HD; Einstein MH; Young M; Anastos K; Herold BC
    Am J Reprod Immunol; 2016 Feb; 75(2):146-54. PubMed ID: 26685115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of immunologic markers in cervicovaginal fluid of HIV-infected and uninfected women: implications for the immunologic response to HIV in the female genital tract.
    Sha BE; D'Amico RD; Landay AL; Spear GT; Massad LS; Rydman RJ; Warner NA; Padnick J; Ackatz L; Charles LA; Benson CA
    J Acquir Immune Defic Syndr Hum Retrovirol; 1997 Nov; 16(3):161-8. PubMed ID: 9390567
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of the Complement System in the Lower Genital Tract During Pregnancy and Delivery.
    Livson S; Jarva H; Kalliala I; Lokki AI; Heikkinen-Eloranta J; Nieminen P; Meri S
    Front Immunol; 2020; 11():563073. PubMed ID: 33505390
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-HIV activity in cervical-vaginal secretions from HIV-positive and -negative women correlate with innate antimicrobial levels and IgG antibodies.
    Ghosh M; Fahey JV; Shen Z; Lahey T; Cu-Uvin S; Wu Z; Mayer K; Wright PF; Kappes JC; Ochsenbauer C; Wira CR
    PLoS One; 2010 Jun; 5(6):e11366. PubMed ID: 20614007
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased levels of immune activation in the genital tract of healthy young women from sub-Saharan Africa.
    Cohen CR; Moscicki AB; Scott ME; Ma Y; Shiboski S; Bukusi E; Daud I; Rebbapragada A; Brown J; Kaul R
    AIDS; 2010 Aug; 24(13):2069-74. PubMed ID: 20588163
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunomodulatory factors in cervicovaginal secretions from pregnant and non-pregnant women: a cross-sectional study.
    Walter J; Fraga L; Orin MJ; Decker WD; Gipps T; Stek A; Aldrovandi GM
    BMC Infect Dis; 2011 Sep; 11():263. PubMed ID: 21961998
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Limited secretory-IgA response in cervicovaginal secretions from HIV-1 infected, but not high risk seronegative women: lack of correlation to genital viral shedding.
    Fiore JR; Laddago V; Lepera A; La Grasta L; Di Stefano M; Saracino A; Lopalco P; Pastore G; Angarano G
    New Microbiol; 2000 Jan; 23(1):85-92. PubMed ID: 10946410
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomized Cross-Sectional Study to Compare HIV-1 Specific Antibody and Cytokine Concentrations in Female Genital Secretions Obtained by Menstrual Cup and Cervicovaginal Lavage.
    Archary D; Liebenberg LJ; Werner L; Tulsi S; Majola N; Naicker N; Dlamini S; Hope TJ; Samsunder N; Abdool Karim SS; Morris L; Passmore JA; Garrett NJ
    PLoS One; 2015; 10(7):e0131906. PubMed ID: 26147923
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.